Effect of mirtazapine and sertraline on BDI score and their link with serotonin transporter gene polymorphism in patients of Major depressive disorders .

Not Applicable

• Conditions: Health Condition 1: null- Major Depressive Disorder

• Registration Number: CTRI/2018/08/015172
• Lead Sponsor: niversity College of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Major Depressive Disorder Patients of both sexes aged between 18 to 45 Years will be included

Exclusion Criteria

Study Participants will be excluded if they have Acute suicidal risk,dementia,schizophrenia,schizoaffective or bipolar diseases,post traumatic disorder,obsessive compulsive disorder ,anxiety,eating disorder,patient on any antidepressant,substance dependency,organic brain disease,pregnant and lactating women and any significant medical illness

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
BDI scores,BDI scale,SERT gene polymorphismTimepoint: BDI scores,BDI scale,SERT gene polymorphism

Secondary Outcome Measures

Name	Time	Method
noneTimepoint: 6 weeks